Diary - News
All news Adocia initiates a clinical study
Adocia announced the initiation of a Phase I clinical trial evaluating a new and more concentrated formulation of BioChaperone Lispro, an ultra-rapid formulation of insulin lispro licensed to Eli Lilly and Company. This formulation uses Adocia’s proprietary BioChaperone technology, which enables the acceleration of insulin absorption.